Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF) Sees Significant Increase in Short Interest

Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPFGet Free Report) was the recipient of a significant growth in short interest during the month of May. As of May 31st, there was short interest totalling 30,200 shares, a growth of 33.6% from the May 15th total of 22,600 shares. Based on an average daily volume of 15,600 shares, the short-interest ratio is currently 1.9 days.

Algernon Pharmaceuticals Price Performance

Algernon Pharmaceuticals stock traded down $0.00 during trading hours on Friday, reaching $0.10. The stock had a trading volume of 19,300 shares, compared to its average volume of 15,044. The company has a fifty day simple moving average of $0.09 and a 200-day simple moving average of $0.07. Algernon Pharmaceuticals has a 52 week low of $0.04 and a 52 week high of $0.18.

About Algernon Pharmaceuticals

(Get Free Report)

Algernon Pharmaceuticals Inc operates as a clinical stage pharmaceutical development company. It focuses on the areas of non-alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, pancreatic and small cell lung cancer, and acute lung injury in Canada and Australia.

Featured Articles

Receive News & Ratings for Algernon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Algernon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.